HALO logo
halo search icon
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

Yuan50.95

Price Change Indicator
-0.64 (-1.241%)
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A
600276 · SHG

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

Start Trading 600276 for Free

Yuan50.95

Price Arrow-0.64 (-1.241%)
20/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusALL-RecommendationsConsensus CheapHALO 100HALO 200HALO AllHALO Balance Sheet+4
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A Overview

600276 Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Weak

Event

Very Strong

HALO Model

Mqv

Weak

Garp

Neutral

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Weak

Dividends

Neutral

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

About 600276

icon
icon

Telephone

86.518.85469805

icon

Address

Economic & Technological Devt Zone, 7 Kunlunshan Road, Lianyungang, Jiangsu 222000

Description

Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. The firm’s products include tablets, oral solution, and suspension of antineoplastic drugs and narcotic drugs; psychotropic substances; soft capsules; freeze-dried powder injection; powder injection; high-volume injection, including multi-layer co-extruded infusion bag, with anti-tumor drugs; small volume injections, including antineoplastic drugs, psychotropic drugs, and non-final sterilization; biological engineering products such as polyethylene glycol recombinant human granulocyte stimulating factor injection; hard capsules; granules; powder; and film and gel. The company was founded in 1970 and is headquartered in Lianyungang, China.

600276 Price Chart

Key Stats

Market Cap

Yuan338.73B

PE

50.20

EV/EBITDA

38.9

Dividends Overview

DIV Yield

0.4%

Franking

0%

Ex Dividend Date (est.)

23-May-25

Market Data

52 weeks range

Low 50.38 - 74.04

Trade Value (12mth)

US$118,970,482.00

1 week

-5.63%

1 month

-8.61%

YTD

-19.23%

1 year

-8.92%

All time high

97.39

Key Fundamentals

EPS 3 yr Growth

93.40%

EBITDA Margin

28.50%

Operating Cashflow

¥11,287m

Free Cash Flow Return

21.10%

ROIC

14.40%

Interest Coverage

594.80

Quick Ratio

7.60

Other Data

Shares Outstanding (Fully Diluted)

6,598m

HALO Sector

Healthcare

Next Company Report Date

19-Apr-27

Next Ex Dividend Date

23-May-25

Next Dividend Pay Date

23-May-25

Reporting Currency

CNY

Short Sell (% of issue)

0.00

600276 Announcements

Latest Announcements

DateAnnouncements
21 August 25
25 October 24
25 September 24
23 August 24

600276 Fundamentals

Per Share Records

Historical data

Forecast data

CNY2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 ¥locklocklocklock0.6811.19locklocklock
EPS (Fully Diluted)
 ¥locklocklocklock0.6811.18locklocklock
Growth
 %locklocklocklock10.447.318.9locklocklock
PE
 Xlocklocklocklock66.84650.2locklocklock
EV/EBITDA
 Xlocklocklocklock54.636.938.9locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

23-May-25

DIV Yield

0.4%

Franking Level

0%

DPSg

14.1%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

HALO Consensus Score

PEG Ratio

Consensus EPS Revisions

Want to learn more?Frequently asked questions.
What is the current share price of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG)?
Halo FAQ
The current share price of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG) is CNY¥50.95.
What is the 52-week high share price for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG)?
Halo FAQ
The 52-week high share price for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG) is CNY¥74.04.
What is the 52-week low share price for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG)?
Halo FAQ
The 52-week low share price for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG) is CNY¥50.38.
What is the dividend yield for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG)?
Halo FAQ
The current TTM dividend payout for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG) is 0.40.
What was Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG) last dividend payment?
Halo FAQ
The last dividend payment of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG) is CNY¥0.20.
What is the franking level for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG)?
Halo FAQ
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG) has a franking level of 0.00%.
In which sector is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG) classified?
Halo FAQ
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG)?
Halo FAQ
The current P/E ratio for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276:SHG) is 50.20.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial